Our study demonstrates that SLAMF7 co-stimulation enhances activation, proliferation, and cytotoxic differentiation of human CD8+ T cells (Figure 4), including those from tumor-draining lymph nodes of HNSCC patients. Here, CD8A is linked to neoplasm.